Integra LifeSciences IART Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $391.92M-9.9% | $434.93M+8.2% | $402.06M-3.3% | $415.61M+8.6% | $382.65M-13.6% | ||
| $174.94M-18.3% | $214.06M+9.7% | $195.07M-5.4% | $206.27M+9.6% | $188.22M-2.8% | ||
| $216.98M-1.8% | $220.87M+6.7% | $206.99M-1.1% | $209.33M+7.7% | $194.43M-21.9% | ||
| 55.4%+4.6pp | 50.8%-0.7pp | 51.5%+1.1pp | 50.4%-0.4pp | 50.8%-5.5pp | ||
| $23.5M-5.2% | $24.79M+10.4% | $22.46M-16.8% | $27M+9.2% | $24.73M-20.8% | ||
| $178.24M+5.3% | $169.27M+0.1% | $169.05M-6.0% | $179.89M-0.9% | $181.5M+1.7% | ||
| $380.45M-7.6% | $411.89M+5.5% | $390.3M-58.0% | $928.28M+133% | $398.15M-2.2% | ||
| $11.47M— | $0-100% | $11.76M+102% | -$512.67M-3,208% | -$15.5M-143% | ||
| 2.9%+2.9pp | 0%-2.9pp | 2.9%+126pp | -123.4%-119pp | -4%-12.1pp | ||
| $22.47M-5.1% | $23.67M+4.2% | $22.73M+8.0% | $21.04M+11.8% | $18.82M-0.9% | ||
| $4.48M— | —— | -$842K+56.7% | -$1.95M-1,251% | -$144K-114% | ||
| -$2.41M— | $0+100% | -$6.82M+98.7% | -$530.95M-1,668% | -$30.04M— | ||
| $2.21M— | —— | -$1.42M+97.0% | -$46.88M-888% | -$4.74M— | ||
| -$4.62M-171% | -$1.7M+68.5% | -$5.4M+98.9% | -$484.07M-1,814% | -$25.29M— | ||
| -1.2%-0.8pp | -0.4%+1.0pp | -1.3%+115pp | -116.5%-110pp | -6.6%— | ||
| -$0.06-200% | -$0.02+71.4% | -$0.07+98.9% | -$6.31-1,812% | -$0.33— | ||
| $53.68M+27.2% | $42.2M-21.9% | $54.01M+111% | -$471.23M-1,956% | $25.4M-67.0% | ||
| 13.7%+4.0pp | 9.7%-3.7pp | 13.4%+127pp | -113.4%-120pp | 6.6%-10.7pp | ||
| $11.47M— | $0-100% | $11.76M+102% | -$512.67M-3,208% | -$15.5M-143% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Integra LifeSciences's revenue?
- Integra LifeSciences (IART) generated $1.6B in revenue over the trailing twelve months, up 1.2% year over year.
- Is Integra LifeSciences profitable?
- Integra LifeSciences is not currently profitable: it reported a net loss of $495.8M over the trailing twelve months, a -30.1% net margin.
- What are Integra LifeSciences's profit margins?
- Gross margin is 51.9% and operating margin is -29.8%, with a -30.1% net margin.
- What is Integra LifeSciences's earnings per share?
- Integra LifeSciences's diluted EPS over the trailing twelve months is $-6.46.
- Where does Integra LifeSciences's income statement data come from?
- Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
